Perspectum

Perspectum® is a medical imaging company that was founded as a spin-out from Oxford University in 2012. We discover, develop and commercialize innovative solutions for the identification and monitoring of metabolic disease and cancer, delivered through software-as-a-service (SaaS). Perspectum has in-house capabilities covering the entire medical device life cycle, driven by a world-leading team of clinicians, engineers and scientists. Our Product Pipeline Perspectum’s flagship product, LiverMultiScan®, is a proprietary, non-invasive, software-based solution that has proven utility and accuracy in stratifying and monitoring patients with liver disorders, including NASH. LiverMultiScan provides three quantitative measures that have been shown to correlate with key features of liver tissue health - fat, iron and fibro-inflammation. LiverMultiScan is cleared for clinical use in the US, EU and several APAC countries. MRCP+ is the most advanced biliary visualization software available, allowing unprecedented quantitative assessment of the bile ducts, pancreatic duct and gall bladder in 3D. It has the potential to transform clinical practice in biliary disorders and liver transplantation. MRCP+ is cleared for clinical use in the US, EU and several APAC countries. Perspectum’s products are all delivered through a centrally read, SaaS model via our cloud-based data management platform, Perspectum Portal. This enables scalable, high-quality delivery through a streamlined process. All images are analyzed by our imaging and clinical specialists, returned as an easy-to-interpret report with quantitative metrics in less than 24 hours. We offer continuous support services from our global team of MRI physicists, imaging scientists and clinicians.